With great sadness, we share the announcement of the passing of Professor Dr. Ulrich auf dem Keller. Ulrich was a world leader in the fields of wound healing and proteinase biology and a pioneer in mass spectrometry-based proteomics technologies. Raised in Mülheim an der Ruhr, Germany, Ulrich spoke Latin and Ancient Greek. Following his passion for science, he received his…
For the first time ever, BC Children’s Hospital Research Institute has produced a mini Year in Review to publicly share a snapshot of research accomplished during the past fiscal year. Research and media coverage highlighted in the Year in Review include improving youth mental health and well-being during the COVID-19 recovery phase in B.C., providing precision care to kids with cancer, a…
Nominations for the 2024 Clinical Trials BC Awards are now open! These awards honour individuals and organizations who have made significant contributions to strengthening the BC clinical trials ecosystem. Award recipients exemplify excellence in leadership, advocacy for clinical trials, and outstanding service and support to advance clinical trials research and improve the health of people across British Columbia. There are…
While people of Asian ancestry make up more than 16 per cent of Canada’s population, they’ve been vastly underrepresented in Alzheimer’s research to date, comprising less than 3 per cent of participants in clinical trials and national data sets. UBC researchers are working to close that gap. Dr. Robin Hsiung, associate professor of neurology and researcher at the Djavad Mowafaghian Centre…
Congratulations to Drs. Tao Huan, Manu Madhav and Brett Hilton on being named 2023 Michael Smith Health Research BC Scholars! The Scholar Program is one of Health Research BC’s flagship funding opportunities and supports early-career health researchers who are building leading-edge health research programs, training the next generation of scientists and expanding their potential to make significant contributions to their…
Mitacs has opened the call for nominations for the 13th Mitacs Awards. One of Canada’s premier innovation celebrations, the awards recognize outstanding Mitacs program participants whose groundbreaking research is fostering innovation and growth. Students and postdoctoral fellows may be nominated for one of six categories (details below) by the post-secondary or industry partner who supervised their work during a Mitacs-funded…
BriaCell Therapeutics Corp. (TSX:BCT, Nasdaq: BCTX), a Vancouver-Philadelphia oncology immunotherapeutics company, is dividing. The company announced today it has spun out two of its pre-clinical pipeline assets into a new company — BriaPro Therapeutics Corp. The two pipeline assets include Bria-TILsRX and protein kinase C delta inhibitors (PKCδ). All of BriaCell’s assets are for treating various forms of cancer. BriaCell…
With great sadness, we share the news that Professor Emerita Dr. Edith (Edie) McGeer passed away on Monday, August 28, 2023 at the age of 99. As a pioneering researcher who made seminal contributions to our understanding of the biochemical pathology of Alzheimer’s and other neurodegenerative diseases, Dr. McGeer leaves behind a legacy of extraordinary achievement and impact in the…
In this Q&A from Dr. Anna Blakney’s lab at the Michael Smith Laboratories and School of Biomedical Engineering, PhD Candidate Petya Popova shares her research on refining lipid nanoparticle formulations to improve the immune response to RNA vaccines for the sexually transmitted infection Chlamydia. Our research aims to explore the differences between mRNA (messenger RNA) and saRNA (self-amplifying RNA) vaccines…
Our research focuses on herpes simplex virus 2 (HSV-2), a sexually transmitted virus that causes lifelong infection and disease. HSV-2 infection affects millions of people around the world, and it disproportionally affects women over men. Despite this global burden, we still do not have a vaccine against HSV-2. The rise in mRNA vaccines may certainly change the course. In fact,…